Endogenous alkaloids in man XXVI. Determination of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in biological samples using gas chromatography with selected ion monitoring

Journal of Chromatography B: Biomedical Applications

Volumn 687, Issue 2, 1996, Pages 337-348

  Bringmann, Gerhard ^a   Friedrich, Heike ^a   Birner, Gerhard ^a   Koob, Michael ^a   Sontag, Karl Heinz ^b   Heim, Christine ^c   Kolasiewicz, Waclaw ^d   Fähr, Silvia ^a   Stäblein, Michaela ^a   God, Ralf ^a   Feineis, Doris ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 Trichloromethyl 1,2,3,4 tetrahydro carboline; Alkaloids; B Carbolines; Chloral hydrate

Indexed keywords

CARBOLINE DERIVATIVE; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DERIVATIZATION; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FECES LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; INTRAVENOUS ADMINISTRATION; ION MONITORING; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; SOLID PHASE EXTRACTION;

ANIMALS; CARBOLINES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; NERVOUS SYSTEM; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0030582743     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(96)00255-1     Document Type: Article

References (41)

1. [1] P. Riederer and K.W. Lange, Curr. Opin. Neurol. Neurosurg., 5 (1992) 295.
2. [2] R.J. Uitti and D.B. Calne, Eur. Neurol., 33 (Suppl. 1) (1993) 6.
3. [3] G.C. Davis, A.C. Williams, S.P. Markey, M.H. Ebert, E.D. Caine, C.M. Reichert and I.J. Kopin, Psychiatr. Res., 1 (1979) 249.
4. [4] J.W. Langston, P.A. Ballard, J.W. Tetrud and I. Irwin, Science, 219 (1983) 979.
5. [5] T.P. Singer, A.J. Trevor and N. Castagnoli Jr., Trends Biochem. Sci., 12 (1987) 266.
6. [6] R. Lewin, Science, 229 (1985) 257.
7. [7] A. Barbeau, M. Roy, T. Cloutier, L. Plasse and S. Paris, Adv. Neurol., 45 (1986) 299.
8. [8] C.M. Tanner, Trends Neurosci., 12 (1989) 49.
9. [9] G. Bringmann, Naturwissenschaften, 66 (1979) 22.
10. [10] M.M. Airaksinen and I. Kari, Med. Biol., 59 (1981) 21.
11. [11] M.M. Airaksinen and I. Kari, Med. Biol., 59 (1981) 190.
12. [12] N.S. Buckholtz, Life Sci., 27 (1980) 893.
13. [13] H. Rommelspacher and R. Susilo, Prog. Drug Res., 29 (1985) 415.
14. [14] M.A. Collins, in A. Brossi (Editor), The Alkaloids, Academic Press, New York, 1986, Vol. 27, pp. 323-358.
15. [15] H. Rommelspacher, T. May and R. Susilo, Planta Med., 57 (Suppl. 1) (1991) 85.
16. [16] A. Brossi, in G.A. Cordell (Editor), The Alkaloids, Academic Press, New York, 1993, Vol. 43, pp. 119-183.
17. [17] S. Ohkubo, T. Hirano and K. Oka, Lancet, 1 (1985) 1272.
18. [18] M.A. Collins and E.J. Neafsey, Neurosci. Lett., 55 (1985) 179.
19. [19] M.A. Collins, E.J. Neafsey, B.Y. Cheng, K. Hurley-Gius, N.A. Ung-Chhun, D.A. Pronger, M.A. Christensen and D. Hurley-Gius, Adv. Neurol., 45 (1986) 179.
20. [20] G. Bringmann, H. Friedrich and D. Feineis, J. Neural Transm., 38 (1992) 15.
21. [21] G. Bringmann and A. Hille, Arch. Pharm., 323 (1990) 567.
22. [22] G. Bringmann, D. Feineis, H. Friedrich and A. Hille, Planta Med., 57 (Suppl. 1) (1991) 73.
23. [23] G. Bringmann, A. Hille, M. Stäblein, K. Peters and H.-G. von Schnering, Liebigs Ann. Chem., (1991) 1189.
24. [24] G. Bringmann, R. God, D. Feineis, W. Wesemann, P. Riederer, W.-D. Rausch, H. Reichmann and K.-H. Sontag, J. Neural Transm., 46 (1995) 235.
25. [25] G. Bringmann, R. God, D. Feineis, B. Janetzky and H. Reichmann, J. Neural Transm., 46 (1995) 245.
26. [26] P. Riederer, G. Bringmann, K. Jellinger, W.-D. Rausch, H. Reichmann, K.-H. Sontag and W. Wesemann, in Projektträger des BMBF "Forschung im Dienste der Gesundheit" (Editor), Morbus Parkinson und andere Basalganglienerkrankungen, Materialien zur Gesundheitsforschung. Schriftenreihe zum Programm der Bundesregierung "Gesundheitsforschung 2000", Wirtschaftsverlag NW, Verlag für Neue Wissenschaft, Bremerhaven, 1995, pp. 139-157.
27. [27] G. Bringmann, D. Feineis, R. God, S. Fähr, W. Wesemann, H.-W. Clement, C. Grote, W. Kolasiewicz, K.-H. Sontag, C. Heim, T.A. Sontag, H. Reichmann, B. Janetzky, W.-D. Rausch, M. Abdel-Mohsen, E. Koutsilieri, M.E. Götz, W. Gsell, B. Zielke and P. Riederer, Biogenic Amines, 12 (1996) 83.
28. [28] H.R. Snyder, C.H. Hansch, L. Katz, S.M. Parmerter and E.L. Spaeth, J. Am. Chem. Soc., 70 (1948) 219.
29. [29] T.W. Rall, in A. Goodman Gilman, T.W. Rall, A.S. Nies and P. Taylor (Editors), Goodman and Gilman's The Pharmacological Basis of Therapeutics, Maxwell Macmillan Pergamon Publishing Corporation, New York, Oxford, Beijing, Säo Paulo, Sydney, Tokyo, Toronto, 8th ed., 1990, pp. 357, 364-365.
30. [30] T. Ertle, D. Henschler, G. Müller and M. Spassovski, Arch. Toxikol., 29 (1972) 171.
31. [31] G. Bringmann, R. God, K. Fornadi and S. Fähr, unpublished results.
32. [32] K.-H. Sontag, C. Heim, T.A. Sontag, R. God, H. Reichmann, W. Wesemann, W.-D. Rausch, P. Riederer and G. Bringmann, J. Neural Transm., 46 (1995) 283.
33. [33] C. Grote, H.-W. Clement, W. Wesemann, G. Bringmann, D. Feineis, R Riederer and K.-H. Sontag, J. Neural Transm., 46 (1995) 275.
34. [34] W.-D. Rausch, M. Abdel-mohsen, E. Koutsilieri, W.W. Chan and G. Bringmann, J. Neural Transm., 46 (1995) 255.
35. [35] B. Janetzky, R. God, G. Bringmann and H. Reichmann, J. Neural Transm., 46 (1995) 265.
36. [36] K. Biemann, Mass Spectrometry: Organic Chemical Applications, McGraw Hill, New York, 1962, pp. 204-250.
37. [37] H. Friedrich, G. Bringmann, W. Kolasiewicz, K.-H. Sontag and W.-D. Rausch, in Fachgruppe Analytische Chemie (Editor), Fortschritte der Analytischen Chemie in Methode und Anwendung, GDCh-Druck, 1993, pp. 310-312.
38. [38] H. Toepfer, HP Peak, 3 (1992) 6.
39. [39] E. Schulte, in F.L. Boschke, W. Fresenius, J.F.K. Huber, E. Pungor, G.A. Rechnitz, W. Simon, T.S. West (Editors), Praxis der Kapillargaschromatographie, Springer Verlag, Berlin, 1983, p. 116.
40. [40] S.A. Barker, R.EW. Harrison, J.A. Monti, G.B. Brown and S.T. Christian, Biochem. Pharmacol., 30 (1981) 9.
41. [41] B.T. Ho, D. Taylor, K.E. Walker and W. McIsaac, Xenobiotica, 2 (1972) 349.